Skip to content. Skip to navigation
Sections
Personal tools
You are here: Home Events Tablet Process Development and Validation and the application of QbD (2 day)
Navigation
Log in


Forgot your password?
New user?
Site Search
 
Search only the current folder (and sub-folders)
 
Document Actions

Tablet Process Development and Validation and the application of QbD (2 day)

Type Training - Paid
Language English
Date November 28, 2011 to
November 29, 2011
Venue Window Conference Venue
13 Windsor Street
Islington, London N1 8QG
GB
Chemistry Specialties
  • medicinal and pharmaceutical chemistry
Chemistry Techniques
  • other
Contact Judy Callanan
PharmaTraining Limited
BioCity, Pennyfoot Street
Nottingham, NG1 1GF
GB
44 (0) 115 9124249
44 (0) 207 6813582
judy@pharma-training-courses.com
Add event to calendar vCal (Windows, Linux)
iCal (Mac OS X)
by Judy Callanan last modified 09-07-11 08:08 AM

This interactive workshop provides up-to-date, relevant and detailed information on the impact of Quality by Design (QbD) on the Development and Validation of tablet manufacturing processes. It will also study the identification and evaluation of Critical Product Attributes and Critical Process Parameters for tablets, and their implications for process control. We develop new concepts including the use of risk and process matrices for risk management. The latest ICH and FDA guidance on Quality by Design and Process Development, published in 2009, will be comprehensively reviewed. By the end of the course, you will . Understand the relationship between the principles of QbD and tablet development and process validation in generic and new product development . Understand the relationship between material properties, formulation development and process development . Understand the processes commonly used to manufacture tablets and the factors which affect them . Recognise how to identify critical processing parameters, and how to incorporate into a process validation program . Understand the principles of PAT, how and where it can be most effectively deployed . Know the latest FDA thinking on Process Development including the three key steps of validation

Speakers

Dr Michael Gamlen is Managing Director of Pharmaceutical Development Services Ltd, a pharmaceutical consultancy based in Nottingham (UK). Dr Gamlen has over 30 years experience of tablet development. Awarded a First Class Honours degree in Pharmacy, specialising in Pharmaceutical Engineering, he studied for a PhD at Nottingham University. He was Head of Tablet Development at the The Wellcome Foundation for 15 years, and worked as an outsourcing manager before starting his consultancy business in 2000.

More information about this event…

« May 2012 »
Su Mo Tu We Th Fr Sa
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31
Sponsors
Web Search
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: